Lactylation Signatures as Predictors of Prognosis and Therapeutic Response in Lung Adenocarcinoma: Implications for Ultrasound-Based Therapeutic Strategies.

Cai Q, Huang C, Huang Y, Bu S, Wang Z

Open source

DOI
10.1177/10849785251407489
Published
2026 Sep
Container
Cancer biotherapy & radiopharmaceuticals
Publisher
Not recorded
Open access
no

Credibility signals

limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1177/10849785251407489,
  title = {Lactylation Signatures as Predictors of Prognosis and Therapeutic Response in Lung Adenocarcinoma: Implications for Ultrasound-Based Therapeutic Strategies.},
  author = {Cai Q and Huang C and Huang Y and Bu S and Wang Z},
  year = {2026},
  journal = {Cancer biotherapy \& radiopharmaceuticals},
  doi = {10.1177/10849785251407489},
  url = {https://doi.org/10.1177/10849785251407489}
}

RIS

TY  - JOUR
TI  - Lactylation Signatures as Predictors of Prognosis and Therapeutic Response in Lung Adenocarcinoma: Implications for Ultrasound-Based Therapeutic Strategies.
AU  - Cai Q
AU  - Huang C
AU  - Huang Y
AU  - Bu S
AU  - Wang Z
PY  - 2026
JO  - Cancer biotherapy & radiopharmaceuticals
DO  - 10.1177/10849785251407489
UR  - https://doi.org/10.1177/10849785251407489
ER  - 

APA

Q, C., C, H., Y, H., S, B., & Z, W. (2026). Lactylation Signatures as Predictors of Prognosis and Therapeutic Response in Lung Adenocarcinoma: Implications for Ultrasound-Based Therapeutic Strategies.. Cancer biotherapy & radiopharmaceuticals. https://doi.org/10.1177/10849785251407489

Source records